Clinical Trial Update: PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PAS-004 in adults with Neurofibromatosis Type 1 and related plexiform neurofibromas; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• PAS-004

Snippet

Sponsor: Pasithea Therapeutics Corp. | Conditions: NF1 Mutation, Neurofibroma Plexiform | Phase 1 | Status: RECRUITING